TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
87.24
-0.62 (-0.71%)
Apr 18, 2024, 4:00 PM EDT - Market closed
TransMedics Group Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 95.14, with a low estimate of 70 and a high estimate of 110. The average target predicts an increase of 9.06% from the current stock price of 87.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TMDX stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $95 | Buy | Initiates | $95 | +8.90% | Mar 28, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $75 → $95 | Hold | Maintains | $75 → $95 | +8.90% | Feb 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $87 → $105 | Buy | Maintains | $87 → $105 | +20.36% | Feb 27, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $92 → $105 | Buy | Maintains | $92 → $105 | +20.36% | Feb 27, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $54 → $75 | Hold | Maintains | $54 → $75 | -14.03% | Dec 4, 2023 |
Financial Forecast
Revenue This Year
374.33M
from 241.62M
Increased by 54.92%
Revenue Next Year
499.77M
from 374.33M
Increased by 33.51%
EPS This Year
-0.23
from -0.77
EPS Next Year
0.33
from -0.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 391.0M | 566.8M | 759.5M | 867.9M |
| Avg | 374.3M | 499.8M | 653.1M | 843.1M |
| Low | 352.8M | 441.1M | 556.6M | 810.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 61.8% | 51.4% | 52.0% | 32.9% |
| Avg | 54.9% | 33.5% | 30.7% | 29.1% |
| Low | 46.0% | 17.8% | 11.4% | 24.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.59 | 1.63 | 2.47 |
| Avg | -0.23 | 0.33 | 2.24 |
| Low | -1.22 | -0.88 | 2.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 656.0% |
| Avg | - | - | 587.5% |
| Low | - | - | 515.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.